Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
E. Mazzuca (Palermo, Italy), P. Baiamonte (Palermo, Italy), C. Gruttad'Auria (Palermo, Italy), M. Algeri (Palermo, Italy), C. Arena (Palermo, Italy), G. Linguanti (Palermo, Italy), A. Castrogiovanni (Solingen, Germany), M. Bonsignore (Palermo, Italy). High rate of intolerance to ASV in patients with Cheynes-Stokes respiration (CSR). 2003

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of adaptative servo-ventilation (ASV) versus continuous positive airway pressure (CPAP) in treatment of cheyne-stokes respiration (CSR) in heart failure (HF) patients Source: Annual Congress 2004 - CPAP therapy for OSA Year: 2004 Low levels of nasal continuous positive airway pressure (CPAP) treatment in patients with congestive heart failure (CHF) and Cheyne-Stokes respiration (CSR) Source: Eur Respir J 2001; 18: Suppl. 33, 505s Year: 2001 Nocturnal oxygen therapy (NOT) versus nasal ventilation with Auto-CS in patients with severe chronic heart failure (CHF) and Cheyne-Stokes respiration (CSR): a long-term study over 2 years Source: Eur Respir J 2002; 20: Suppl. 38, 9s Year: 2002 Mortality in heart failure patients with nocturnal Cheyne-Stokes respiration receiving adaptive servoventilation (ASV) therapy Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Sensitivity and specificity of ventilatory response to carbon dioxide as a predictor of Cheyne Stokes respiration (CSR) in patients with congestive heart failure (CHF) Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002 Efficacy of and compliance to adaptative servo-ventilation (ASV) for sleep apnea syndrome (SAS) with cheyne-stokes respiration (CSR) in cardiologic versus non-cardiologic patients Source: Eur Respir J 2004; 24: Suppl. 48, 563s Year: 2004 Heart rate variability (HRV) and blood pressure (BP) changes in patients with neuromuscular disease (NMD) following setup of non-invasive ventilation (NIV) Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Prognostic utility of metabolic index (M.I), respiratory quotient (R.Q), ventilatory oxygen consumption (VO2) as markers of metabolic stress in mechanically ventilated versus spontaneously breathing critically ill pediatric patients Source: Eur Respir J 2006; 28: Suppl. 50, 631s Year: 2006 FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results. Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea Year: 2020 Influence of non-medicamentous methods of treatment on heart rate variability (HRV) at patients with bronchial asthma (BA) Source: Eur Respir J 2005; 26: Suppl. 49, 183s Year: 2005 COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level Source: Annual Congress 2012 - COPD exacerbation Year: 2012 High O2 flow rate is necessary to reach acceptable FiO2 levels in CPAP-treated patients with severe COVID-19 Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Hypercapnic and isocapnic hypoxic ventilatory response (VR) in stable heart failure (HF) patients with and without cheyne-stokes-respiration (CSR) Source: Eur Respir J 2002; 20: Suppl. 38, 298s Year: 2002 Higher than expected prevalence of alpha-1-antitrypsin deficiency (AATD) may not necessarily impact on airflow, gas exchange or acute exacerbation rate (AER) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Noninvasive ventilation (NIV) after lung resection (LR) to prevent respiratory complications (RCs) in COPD patients (pts) (POPVNI trial) Source: Annual Congress 2011 - Noninvasive ventilation in the acute setting: education, organisation, H1N1, paediatrics, weaning, diagnostic procedures and special considerations Year: 2011 Changes of heart rate variability in different types of breathing in patients with bronchial asthma (BA) Source: Eur Respir J 2001; 18: Suppl. 33, 34s Year: 2001 Predicting failure of non invasive ventilation (NIV) and High flow nasal cannula (HFNC) in patients with acute hypoxemic hypocapnic respiratory failure (AHHRF): the usefulness of the standardised PaO2/FiO2 ratio (P/F-st). Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores Year: 2020 Anabolic response during incremental and constant work rate exercise testing in COPD patients after an acute exacerbation (AE) Source: Eur Respir J 2002; 20: Suppl. 38, 565s Year: 2002 Association of impaired ventilatory efficiency with Chyene-Stokes respiration in patients with chronic heart failure Source: Eur Respir J 2002; 20: Suppl. 38, 292s Year: 2002